- The total purchase consideration for Opto-Pharm is S$14.3 million

 

- Acquisition at an Attractive Valuation: The Consideration represents a discount of approximately 7.52% to the Net Tangible Assets (“NTA”) of the Target Group as at 30 June 2026, principally due to the current under-utilisation of the 11 Tuas Avenue Property.

 

- Creation of Recurring Income Streams: Subject to obtaining the necessary regulatory approvals, the Group intends to develop ancillary workers’ dormitory facilities within the Properties. The Board believes that this will provide the Group with a stable and recurring rental income stream. Given the continued shortage of quality workers’ dormitory accommodation in Singapore, particularly within established industrial estates, the Board expects such facilities to enjoy sustained demand while also supporting the accommodation needs of the Group’s workforce.

 

- Unlocking Value of Under-Utilised Assets: The Proposed Acquisition provides the Group with the opportunity to unlock the development potential of the Properties through redevelopment, refurbishment and more efficient utilisation of the available land, thereby enhancing the long-term value of the assets

 

- Expansion of the Group’s Operational Capacity: The Proposed Acquisition provides the Group with additional industrial facilities and land adjacent to its existing operations, thereby enabling the Group to consolidate and expand its manufacturing, warehousing, logistics and ancillary support functions. The close proximity of the Properties to the Company’s existing factory at 5 Tuas Avenue 12, Singapore 639025 is expected to enhance operational efficiency, improve workflow integration, reduce transportation costs and provide capacity for future business growth.